Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroprotective Activities of Crossyne flava Bulbs and Amaryllidaceae Alkaloids: Implications for Parkinson’s Disease

30 Jun 2021

Abstract excerpt

Parkinson’s disease (PD) is one of the most common neurodegenerative diseases and affects approximately 6.3 million people worldwide. To date, the treatment of PD remains a challenge, as available treatment options are known to be associated with serious side effects; hence, the search for new treatment strategies is critical. Extracts from the Amaryllidaceae plant family as well as their alkaloids have been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemical synthesis and alkaloids
Share to Cholinesterase and Neurodegenerative Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34208814
DOI: 10.3390/molecules26133990

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroprotective Activities of Crossyne flava Bulbs and Amaryllidaceae Alkaloids: Implications for Parkinson’s DiseasePMID 34208814Read ↗

Boophone Haemanthoides (Amaryllidaceae) and Its Bioactive Compounds Attenuate MPP+-Induced Toxicity in an in Vitro Parkinson’s Disease ModelSemantic proximity Read ↗

Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson’s diseaseSemantic proximity Read ↗

Levodopa-Reduced Mucuna pruriens Seed Extract Shows Neuroprotective Effects against Parkinson’s Disease in Murine Microglia and Human Neuroblastoma Cells, Caenorhabditis elegans, and Drosophila melanogasterSemantic proximity Read ↗

Molecular insight into the mechanism of action of some beneficial flavonoids for the treatment of Parkinson’s DiseaseSemantic proximity Read ↗

Bacopaside-I ameliorates motor dysfunction and neurodegeneration in rat model of Parkinson’s diseaseSemantic proximity Read ↗

Scopoletin Augments DJ1/Nrf2 Signalling and Prevents Protein Aggregation in Parkinson’s diseaseSemantic proximity Read ↗

Neuroprotective activity of isoquinoline alkaloids from of Chilean Amaryllidaceae plants against oxidative stress-induced cytotoxicity on human neuroblastoma SH-SY5Y cells and mouse hippocampal slice cultureSemantic proximity Read ↗

Multi-modal neuroprotection of Argemone mexicana L. against Alzheimer’s disease: In vitro and in silico studySemantic proximity Read ↗

Investigation of the Mechanisms of Neuroprotection Mediated by Lobelia Species via Computational Network Pharmacology and Molecular ModelingSemantic proximity Read ↗

Purpurin: A natural anthraquinone with multifaceted pharmacological activitiesSemantic proximity Read ↗

The alleviative effect of Calendula officinalis L. extract against Parkinson’s disease-like pathology in zebrafish via the involvement of autophagy activationSemantic proximity Read ↗

Exploring the anti-convulsant potential of cordia dichotoma leaf extract to combat seizures in swiss albino miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.